Boston Scientific Corporation (BSX) Q3 2024 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Conference Call October 23, 2024 8:00 AM ET

Company Participants

Jonathan Monson - Senior Vice President, Investor Relations
Michael Mahoney - Chairman and Chief Executive Officer
Daniel Brennan - Executive Vice President and Chief Financial Officer
Kenneth Stein - Senior Vice President, Global Chief Medical Officer

Conference Call Participants

Robert Marcus - JPMorgan
Joanne Wuensch - Citigroup Inc.
Lawrence Biegelsen - Wells Fargo Securities
Frederick Wise - Stifel, Nicolaus & Company
David Roman - Goldman Sachs
Patrick Wood - Morgan Stanley
Travis Steed - Barclays Bank
Danielle Antalffy - UBS
Anthony Petrone - Mizuho Group
Vijay Kumar - Evercore ISI
Matt Miksic - Barclays
Joshua Jennings - TD Cowen
Matthew O'Brien - Piper Sandler

Operator

Good morning and welcome to the Boston Scientific Third Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Jon Monson, Senior Vice President, Investor Relations. Please go ahead.

Jonathan Monson

Thanks, Drew, and thanks everyone for joining us. With me today are Mike Mahoney, Chairman and Chief Executive Officer; and Dan Brennan, Executive Vice President and Chief Financial Officer. During the Q&A session, Mike and Dan will be joined by our Chief Medical Officer, Dr. Ken Stein and Art Butcher, President of our MedSurg and Asia Pacific businesses.

We issued a press release earlier this morning announcing our Q3 results, which included reconciliations of the non-GAAP measures used in this release. The release as well as reconciliations of the non-GAAP measures used in today's call can be found on the Investor Relations section of our website.

Please note, on the call, operational revenue excludes the impact